Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Gabriel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonistHanbiao Yang, Xiao-Fa Lin, Fernando Padilla, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2010
Synthesis, SAR and evaluation of [1,4']-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Nicole Manser, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Spiropiperidine CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Ferenc Makra, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonistHanbiao Yang, Xiao-Fa Lin, Fernando Padilla, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2010
Synthesis, SAR and evaluation of [1,4']-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Nicole Manser, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Spiropiperidine CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Ferenc Makra, et al.
Pageof 1